Premium
Should cyclophosphamide be a first‐line medication for class V lupus nephritis? Comment on the article by Hahn et al
Author(s) -
Du Xin,
Su Dinglei,
Cao Changchun
Publication year - 2012
Publication title -
arthritis care and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.032
H-Index - 163
eISSN - 2151-4658
pISSN - 2151-464X
DOI - 10.1002/acr.21830
Subject(s) - lupus nephritis , cyclophosphamide , class (philosophy) , medicine , systemic lupus erythematosus , first line , line (geometry) , dermatology , philosophy , mathematics , epistemology , geometry , disease , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom